Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.161ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.69 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.46ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.139ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.508ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.94ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.463ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.357ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.318ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.557ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.119ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.160ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
D.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.447ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.110.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.180ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.155ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.92ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.145ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.120ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.77ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AE.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.504ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20103.9China
AE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.201ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.221ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.410ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.411ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.310ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.185ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.329ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.229ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.342ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.90ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.169ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.528ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.175ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.6.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.483ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.181ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.113ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.594ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.328ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.145ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.547ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.247ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used